Xtandi 40 MG capsule 120S

Ended Awarded

Contract number
SPE2DB23FYQ93
Awardee
Awarding agency
Obligated
$4,311

Award facts

Contract value 100% obligated
$4,311.35 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Park Ridge, IL 60068, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency awarded a firm fixed price delivery order valued at four thousand three hundred eleven dollars and thirty-five cents ($4,311.35) to DMS Pharmaceutical Group Inc. to supply one hundred twenty (120) 40mg capsules of XTANDI, an oncology pharmaceutical, for use by the Department of Defense. Performance will take place at the prime contractor's facility located in Park Ridge, Illinois between September 5-6, 2023. No subcontractors or set aside designations were identified. The delivery order was issued under an existing DLA pharmaceutical supply contract vehicle to fulfill oncology medication requirements for DOD personnel and activities.

Quick answers

Who was awarded contract SPE2DB23FYQ93?

SPE2DB23FYQ93 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 5, 2023.

How much is contract SPE2DB23FYQ93 worth?

The government has obligated $4,311 on SPE2DB23FYQ93.

Is contract SPE2DB23FYQ93 an order under another contract?

Yes. SPE2DB23FYQ93 is a delivery order under SPE2DB22D9316, an indefinite delivery contract.

Was contract SPE2DB23FYQ93 competed?

The extent of competition for SPE2DB23FYQ93 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award